Literature DB >> 12951036

Expression of a foreign gene by stable recombinant influenza viruses harboring a dicistronic genomic segment with an internal promoter.

Alexandre Vieira Machado1, Nadia Naffakh, Sylvie van der Werf, Nicolas Escriou.   

Abstract

Based on the observation that an internally located 3' promoter sequence can be functional (R. Flick and G. Hobom, Virology, 1999, 262(1), 93-103), we generated transfectant influenza A viruses harboring a dicistronic segment containing the CAT gene (660 nt) or a fragment of the Mengo virus VP0 capsid gene (306 nt) under the control of a duplicated 3' promoter sequence. Despite slightly reduced NA expression, the transfectant viruses replicated efficiently and proved to be stable upon both serial passage in vitro in MDCK cells and in vivo replication in the pulmonary tissue of infected mice. Internal initiation of replication and transcription from the second, internal, 3' promoter directed the synthesis of subgenomic vRNA and mRNA and therefore permitted expression of the foreign gene product, e.g., the CAT enzyme. The design of this vector may prove particularly appropriate for the utilization of influenza virus for the expression of heterologous proteins in their native form.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12951036     DOI: 10.1016/s0042-6822(03)00289-7

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  9 in total

1.  Establishment of a chimeric, replication-deficient influenza A virus vector by modulation of splicing efficiency.

Authors:  Markus Wolschek; Elisabeth Samm; Helena Seper; Sanda Sturlan; Irina Kuznetsova; Cornelia Schwager; Alexandra Khassidov; Christian Kittel; Thomas Muster; Andrej Egorov; Michael Bergmann
Journal:  J Virol       Date:  2010-12-22       Impact factor: 5.103

2.  Generation of an influenza A virus vector expressing biologically active human interleukin-2 from the NS gene segment.

Authors:  Christian Kittel; Boris Ferko; Martina Kurz; Regina Voglauer; Sabine Sereinig; Julia Romanova; Gabriela Stiegler; Hermann Katinger; Andrej Egorov
Journal:  J Virol       Date:  2005-08       Impact factor: 5.103

3.  Incorporation of influenza A virus genome segments does not absolutely require wild-type sequences.

Authors:  Ken Fujii; Makoto Ozawa; Kiyoko Iwatsuki-Horimoto; Taisuke Horimoto; Yoshihiro Kawaoka
Journal:  J Gen Virol       Date:  2009-03-18       Impact factor: 3.891

4.  Generation of recombinant lymphocytic choriomeningitis viruses with trisegmented genomes stably expressing two additional genes of interest.

Authors:  Sebastien F Emonet; Lucile Garidou; Dorian B McGavern; Juan C de la Torre
Journal:  Proc Natl Acad Sci U S A       Date:  2009-02-10       Impact factor: 11.205

5.  Immunogenicity of a recombinant influenza virus bearing both the CD4+ and CD8+ T cell epitopes of ovalbumin.

Authors:  Bruno Garulli; Giuseppina Di Mario; Ester Sciaraffia; Yoshihiro Kawaoka; Maria R Castrucci
Journal:  J Biomed Biotechnol       Date:  2011-10-05

6.  Protective immunity and safety of a genetically modified influenza virus vaccine.

Authors:  Rafael Polidoro Alves Barbosa; Ana Paula Carneiro Salgado; Cristiana Couto Garcia; Bruno Galvão Filho; Ana Paula de Faria Gonçalves; Braulio Henrique Freire Lima; Gabriel Augusto Oliveira Lopes; Milene Alvarenga Rachid; Andiara Cristina Cardoso Peixoto; Danilo Bretas de Oliveira; Marco Antônio Ataíde; Carla Aparecida Zirke; Tatiane Marques Cotrim; Érica Azevedo Costa; Gabriel Magno de Freitas Almeida; Remo Castro Russo; Ricardo Tostes Gazzinelli; Alexandre de Magalhães Vieira Machado
Journal:  PLoS One       Date:  2014-06-13       Impact factor: 3.240

7.  Influenza A virus encoding secreted Gaussia luciferase as useful tool to analyze viral replication and its inhibition by antiviral compounds and cellular proteins.

Authors:  Nadine Eckert; Florian Wrensch; Sabine Gärtner; Navaneethan Palanisamy; Ulrike Goedecke; Nils Jäger; Stefan Pöhlmann; Michael Winkler
Journal:  PLoS One       Date:  2014-05-19       Impact factor: 3.240

8.  Vaccination using recombinants influenza and adenoviruses encoding amastigote surface protein-2 are highly effective on protection against Trypanosoma cruzi infection.

Authors:  Rafael Polidoro Alves Barbosa; Bruno Galvão Filho; Luara Isabela Dos Santos; Policarpo Ademar Sales Junior; Pedro Elias Marques; Rafaela Vaz Sousa Pereira; Denise Carmona Cara; Oscar Bruña-Romero; Maurício Martins Rodrigues; Ricardo Tostes Gazzinelli; Alexandre Vieira Machado
Journal:  PLoS One       Date:  2013-04-24       Impact factor: 3.240

Review 9.  Replication-Competent Influenza A Viruses Expressing Reporter Genes.

Authors:  Michael Breen; Aitor Nogales; Steven F Baker; Luis Martínez-Sobrido
Journal:  Viruses       Date:  2016-06-23       Impact factor: 5.048

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.